Chemical Structure (Demerol 01)
Demerol Injection, Solution
Product Images NDC 0409-1178
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Demerol (NDC 0409-1178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Demerol 02)
Demerol 02a
Description: The text provides instructions for using the NexJect 1mL Prefilled Syringe. It advises visually inspecting the product for broken tamper-evident seals and obtaining a new one if found. It also recommends confirming that the medication order matches the prescribed drug name, strength, dose, and route of administration before using it. Furthermore, the text instructs not to use any of the above-presented materials, and do not place the syringe in a sterile field. Finally, it suggests not to recap the needle if utilized.*
Demerol 02b
Demerol 02c
Demerol 02d
Principal Display Panel (25 mg/mL Cartridge Label)
The description is: "Single-dose Carpuject Sterile Cortridge with Luer Lock containing Demerol injection, distributed by Hospira, Inc. with the NDC 0403-1176-03. Lot and expiration date provided as LOT susesan and EXP DHMMYYYY. T T T"*
Principal Display Panel (25 mg/mL Cartridge Carton)
This is a packaging label for a single-dose injection of the medication Demerol (meperidine hydrochloride) in a Carpuject™ Cartridge with Luer Lock. The label includes details such as dosage, manufacturer information, and instructions for use. A needle is not included and the medication is only to be used with Carpuject Holders.*
Principal Display Panel (50 mg/mL Cartridge Label)
This appears to be a label of a pharmaceutical product called "Demerol", which is an injection containing eperidine HCI, manufactured by a company named Hospira, Inc. in Lake Forest, IL, USA. The label also indicates a single-dose Carpuject with a locking mechanism, and the drug's lot number and expiry date.*
Principal Display Panel (50 mg/mL Cartridge Carton)
This description is for meperidine hydrochloride injection, which is a pain-relieving medication. The text describes the product details, such as the dosage, how it is meant to be administered, and its storage instructions. The medication is in a sterile container with a Luer Lock that is to be used with a Carpuject Holder. The text also mentions that the medication is a registered trademark of Demerol.*
Principal Display Panel (75 mg/mL Cartridge Label)
This is a description of a medical product called "Demerol". It is an injection that contains meperidine HCl. The concentration of the active ingredient is 75 mg/mL. The product has been manufactured by a company named Hospira and distributed in the USA at Lake Forest, IL. The lot number for the product is FAATZ7583. The product has an expiration date indicated as DRIHRYYYY, which is not readable.*
Principal Display Panel (75 mg/mL Cartridge Carton)
Principal Display Panel (100 mg/mL Cartridge Label)
The text describes a single-dose cartridge containing Demerol, a brand name for meperidine hydrochloride (HC) injection. The cartridge has a capacity of 100mg/mL LoT swwsshn and is distributed by Hospira Inc, located in Lake Forest, IL. There is also an expiration date mentioned as EXP DIIAAYYYY.*
Principal Display Panel (100 mg/mL Cartridge Carton)
This text appears to be a product label for a Single-dose Demerol Sterile Cartridge Units injection, USP. The product contains meperidine hydrochloride and is registered by Carpuject. The dosage and route of injection are provided on the label, and the injection must be used with the Carpuject holders. The product is distributed by Hospira Inc.*
Principal Display Panel (25 mg/0.5 mL Ampule Label)
This is a product description for a 30mL multiple-dose vial of Sterile Aqueous Injection containing meperidine hydrochloride, commonly referred to as Demerol. The vial has a concentration of 50 mg/mL, containing a total of 1500 mg of medication. It can be used for Intramuscular, Subcutaneous, or Intravenous Use, and is available by prescription only. The product is distributed by Hospira, Inc. and is produced in Lake Forest, Illinois, USA.*
Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak)
This is a drug label for Demerol, which contains the active ingredient meperidine hydrochloride. It comes in a 30 mL multiple-dose vial with 0.1% metacresol as a preservative. The drug is administered intramuscularly, subcutaneously or intravenously, and the usual dosage and route of use can be found in the package insert. The solution has a pH adjusted with NaOH or HC and should be stored at 20-25°C. The label contains information on the manufacturer, lot number, and expiration date.*
Principal Display Panel (25 mg/0.5 mL Ampule Dose Pak Carton)
This is a description of an injectable medication called Demerol. It comes in a multiple-dose vial with 2000mg of the drug per 20mL, and has a strength of 100mg/mL. The medication, containing meperidine hydrochloride, is intended for intramuscular, subcutaneous, or intravenous use. The drug is distributed by Hospira, Inc., with headquarters in Lake Forest, Illinois.*
Principal Display Panel (50 mg/mL Ampule Label)
Principal Display Panel (50 mg/mL Ampule Dose Pak)
Principal Display Panel (50 mg/mL Ampule Dose Pak Carton)
The text seems to describe a tamper seal for a single-dose syringe. It includes a barcode with a code number and a LOT number with an expiration date. The seal may require twisting and pulling to open, and does not have a varnished overlap area.*
Principal Display Panel (75 mg/1.5 mL Ampule Label)
This is a product description for Demerol, which is an injectable medication comprised of meperidine hydrochloride. It is prescribed for intramuscular, subcutaneous, or intravenous use. There are 10 NexJect 1 mL single-dose syringes with luer lock included, but needles are not part of the packaging. It should be stored at a controlled room temperature. Sodium chloride is added to pH the sterile aqueous injection. This medication is a registered trademark of S and its usual dosage and usage can be found in the package insert. The GTIN is 10304091362034 and has an EXP date of DHMNMYYYY.*
Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak)
Principal Display Panel (75 mg/1.5 mL Ampule Dose Pak Carton)
Principal Display Panel (100 mg/2 mL Ampule Label)
This is a description of the medication Demerol™, also known as meperidine hydrochloride. It comes in 1 mL single-dose syringes with a luer lock and is used for intramuscular, subcutaneous, or intravenous injection. It is a sterile aqueous injection with DH adjusted with NaOH or HCL. The usual dosage and route of administration can be found in the package insert. Demerol™ is a registered trademark of Sanofi Pharmaceutical, Inc. The GTIN is 0D304DAL41A0ML and the expiration date is listed as DHAMYYYY. The medication should be stored at 20°C to 25°C (68°F to 77°F).*
Principal Display Panel (100 mg/2 mL Ampule Dose Pak)
Not available.*
Principal Display Panel (100 mg/2 mL Ampule Dose Pak Carton)
This appears to be a product label for a single-dose syringe. It includes a lot number and expiration date. There is also mention of "NoVarnish - Overlap Area" which may be a feature of the syringe. The other text, such as "A" and "FP0 GS51 DataBar Limited 8.5 Mil" is not clear how it relates to the product.*
Principal Display Panel (100 mg/mL Ampule Label)
This is a description of Demerol™ medication. Each of the ten NexJect™ syringes contains 1 mL of meperidine hydrochloride solution. This medication is intended for intramuscular, subcutaneous, or intravenous use only, and a needle is not included. It is stored at controlled room temperature (20-25°C) and supplied sterile. The solution is adjusted with acid or base, and the usual dosage and administration directions are provided in the package insert. Demerol™ is a registered trademark of Sanofi Pharmaceuticals, Inc. There are additional details on the packaging related to the expiration date and lot number.*
Principal Display Panel (100 mg/mL Ampule Dose Pak)
This is not available.*
Principal Display Panel (100 mg/mL Ampule Dose Pak Carton)
This is a description of an L single-dose syringe that comes with a limited GS1 DataBar of 8.5 Mil. It has a LOT number and an expiration date displayed in the format DMMMYYYY. The syringe features a TWIST&PULL method and has an overlap area with no varnish.*
Principal Display Panel (30 mL Vial Label)
This is a description of Demerol, a medication used for intramuscular, subcutaneous or intravenous administration. It contains meperidine hydrochloride and comes in a pack of ten 1mL single-dose syringes with luer lock, with the needle not included. The medication is stored at a controlled room temperature and is a sterile aqueous injection that is pH adjusted with either NaO H or HCL. The usual dosage and route of administration can be found in the package insert. This medication is a registered trademark of Sanofi Pharmaceutical, Inc. The barcode, lot, and expiration date are also provided.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
